Business

UPDATE: Collegium to Participate in Upcoming Conferences

STOUGHTON, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the

articleCollegium Pharmaceutical, Inc.November 11, 20215/company/collegium-pharmaceutical-inc/news/update-collegium-to-participate-in-upcoming-conferences-2021-11-11
UPDATE: Collegium to Participate in Upcoming Conferences

About this update from Collegium Pharmaceutical, Inc.

[{"type":"text","content":"STOUGHTON, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conferences: Jefferies London Healthcare ConferenceVirtual one-on-one meetingsDate: Thursday, November 18, 2021 Piper Sandler Annual Healthcare Conference 2021Virtual fireside chatDate: Wednesday, December 1, 2021 The fireside chat will be webcast and may be accessed from the Investor section of the Company’s website: https://ir.collegiumpharma.com. A replay of the webcast will be available on the Company’s website for approximately 30 days after the event. About Collegium Pharmaceutical, Inc. Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the company’s website at www.collegiumpharma.com. Contact:\nMacDougall Advisors\[email protected]\nSource: Collegium Pharmaceutical, Inc.","length":2947,"tagName":"div"}]

More updates from Collegium Pharmaceutical, Inc.